Spots Global Cancer Trial Database for embryonal tumor
Every month we try and update this database with for embryonal tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Rare Embryonal Tumors of the Central Nervous System: International Registry | NCT05711992 | Embryonal Tumor | 1 Day - 25 Years | Immune Oncology Research Institute | ||
| Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development | NCT00340522 | Cancer | - 25 Years | National Institutes of Health Clinical Center (CC) | ||
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | NCT05259605 | Glioma Glioneuronal Tu... Choroid Plexus ... Pineal Tumors Germ Cell Tumor Tumor of the Se... Diffuse Midline... Ependymoma Embryonal Tumor Pineal Tumor Hemangiopericyt... Hemangioblastom... Melanocytic Tum... | Observational | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas | NCT06323408 | Glioma, Maligna... Embryonal Tumor Medulloblastoma Ependymoma | Tissue, blood, ... | 15 Years - 39 Years | University Hospital Regensburg | |
| Rare Embryonal Tumors of the Central Nervous System: International Registry | NCT05711992 | Embryonal Tumor | 1 Day - 25 Years | Immune Oncology Research Institute | ||
| HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors | NCT02457845 | Supratentorial ... Malignant Gliom... Glioblastoma Anaplastic Astr... PNET Cerebral Primit... Embryonal Tumor | G207 | 3 Years - 18 Years | University of Alabama at Birmingham | |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | NCT05259605 | Glioma Glioneuronal Tu... Choroid Plexus ... Pineal Tumors Germ Cell Tumor Tumor of the Se... Diffuse Midline... Ependymoma Embryonal Tumor Pineal Tumor Hemangiopericyt... Hemangioblastom... Melanocytic Tum... | Observational | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development | NCT00340522 | Cancer | - 25 Years | National Institutes of Health Clinical Center (CC) | ||
| Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients | NCT05293197 | Malignant Brain... Malignant Gliom... Embryonal Tumor | SonoCloud® (9 t... | 5 Years - 17 Years | Assistance Publique - Hôpitaux de Paris | |
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors | NCT05278208 | High Grade Glio... Meningioma Embryonal Tumor Medulloblastoma Anaplastic Epen... Recurrent Diffu... Recurrent Malig... Recurrent Medul... Recurrent Prima... Refractory Diff... Refractory Mali... Refractory Medu... Refractory Prim... | LUTATHERA® (Lut... | 4 Years - | Nationwide Children's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
